Loading the player...
Closed Captioning / Subtitles Available
Information
Advanced Psychopharmacology for Clinicians: Using Psychopharmacology to Understand and Treat Addiction Disorders
Copyright :
Common medications used to treat substance use disorders like naltrexone, naloxone and methadone can be easy to confuse… and hard to understand even for the most seasoned professionals.
And, that’s just the beginning… Drug testing, poly-substance abuse, and co-occurring mental health problems create more obstacles.
Not only does award-winning researcher, author and board-certified clinical psychiatric pharmacist, David Dadiomov, PharmD, BCPP bring clarity to the latest research on Substance Use Disorders (SUD) and the role antidepressants, antipsychotics, psychedelics can play…
He’ll walk you through specific, easy-to-apply strategies on high-risk prescription opioid use, therapeutic drug monitoring, substance intoxication and withdrawal, treatment-resistant psychiatric conditions and more.
Whether you work in direct patient care or allied health settings… you’ll be able to apply his interventions to immediately see improved outcomes for your patients.
You’ll get unique and practical case studies and a simplified, comprehensive guide for medication and non-medication interventions for nearly most SUDs so you can quickly respond to signs of substance-use related emergencies and know how SUDs impact various health conditions… even for your most vulnerable patient populations.
Whether you’re a prescriber or not, you’ll get you need to stay up to speed on a rapidly changing field to improve your treatment outcomes and protect your license!
David Dadiomov, PharmD, BCPP
David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.
He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.
Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.
He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.
Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.
Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, the University of Southern California Psychiatry and Behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the College of Psychiatric and Neurologic Pharmacists, the American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.
